Attitudes about tuberculosis prevention in the elimination phase: A survey among physicians in Germany

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Gutsfeld, Christian ^a,b   Olaru, Ioana D ^a   Vollrath, Oliver ^c   Lange, Christoph ^a,d,e,f  

^a RESEARCH CENTER BORSTEL   (Germany)

^b Department of Psychosomatic Medicine ^*  (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d UNIVERSITY OF LÜBECK   (Germany)

^e UNIVERSITY OF NAMIBIA   (Namibia)

^f KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR INHIBITOR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; IMMUNOSUPPRESSIVE AGENT; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; GERMANY; HEALTH CARE SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; INTERFERON GAMMA RELEASE ASSAY; MEDICAL DECISION MAKING; MIDDLE AGED; MIGRANT; ONLINE SYSTEM; PHYSICIAN ATTITUDE; POPULATION EXPOSURE; PROFESSIONAL KNOWLEDGE; PULMONOLOGIST; RISK FACTOR; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS CONTROL; WORK EXPERIENCE; YOUNG ADULT; ANTAGONISTS AND INHIBITORS; ATTITUDE; DISEASE ERADICATION; DRUG EFFECTS; FEMALE; HIV INFECTIONS; INFORMATION PROCESSING; ISOLATION AND PURIFICATION; MALE; METABOLISM; MICROBIOLOGY; MIGRATION; MIXED INFECTION; MYCOBACTERIUM TUBERCULOSIS; ORGANIZATION AND MANAGEMENT; PHYSICIAN; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA; TUBERCULOSIS, PULMONARY; VIROLOGY;

ADULT; ANTI-HIV AGENTS; ANTITUBERCULAR AGENTS; ATTITUDE; COINFECTION; DATA COLLECTION; DISEASE ERADICATION; FEMALE; GERMANY; HIV INFECTIONS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PHYSICIANS; RISK FACTORS; TRANSIENTS AND MIGRANTS; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84911916415     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112681     Document Type: Article

References (70)

1. World Health Organization (2013) Global tuberculosis report 2013. Geneva, Switzerland.
2. Robert Koch Institute (2013) Bericht zur Epidemiologie der Tuberkulose in Deutschland für 2011 Robert Koch-Institut, Berlin 2013. 99-103.
3. Erkens CG, Kamphorst M, Abubakar I, Bothamley GH, Chemtob D, et al. (2010) Tuberculosis contact investigation in low prevalence countries: a European consensus. Eur Respir J 36: 925-949.
4. Mack U, Migliori GB, Sester M, Rieder HL, Ehlers S, et al. (2009) LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J 33: 956-973.
5. Infectious Diseases Protection Law (Gesetz zur Verhütung und Bekämpfung von Infektionskrankheiten beim Menschen, Infektionschutzgesetz IFSG). 125 1-3 II, July 2000. Available: www.rki.de. Accessed 2014 May.
6. Schaberg T, Bauer T, Castell S, Dalhoff K, Detjen A, et al. (2012) [Recommendations for therapy, chemoprevention and chemoprophylaxis of tuberculosis in adults and children. German Central Committee against Tuberculosis (DZK), German Respiratory Society (DGP)]. Pneumologie 66: 133-171.
7. Diel R, Loytved G, Nienhaus A, Castell S, Detjen A, et al. (2011) [New recommendations for contact tracing in tuberculosis]. Gesundheitswesen 73: 369-388.
8. Fallab-Stubi CL, Zellweger JP, Sauty A, Uldry C, Iorillo D, et al. (1998) Electronic monitoring of adherence to treatment in the preventive chemotherapy of tuberculosis. Int J Tuberc Lung Dis 2: 525-530.
9. Robert Koch-Institute (2013) Anwendung und Akzeptanz der präventiven Behandlung bei Kindern mit Kontakt zu Tuberkulose-Erkrankte. Epidemiologisches Bulletin Nr 12.
10. Diel R, Loddenkemper R, Niemann S, Meywald-Walter K, Nienhaus A (2011) Negative and positive predictive value of a whole-blood interferon-gamma release assay for developing active tuberculosis: an update. Am J Respir Crit Care Med 183: 88-95.
11. European Centre for Disease Prevention and Control (2010) Progressing towards TB elimination. Stockholm: ECDC.
12. World Health Organization Media Center. New action plan lays the foundation for tuberculosis elimination. Issued on October 10th 2010. Available: http://www.who.int/mediacentre/news/releases/2010/tb-20101013/en/, Accessed 2014 Sep 5.
13. Chee CB, Sester M, Zhang W, Lange C (2013) Diagnosis and treatment of latent infection with Mycobacterium tuberculosis. Respirology 18: 205-216.
14. Chegou NN, Heyckendorf J, Walzl G, Lange C, Ruhwald M (2013) Beyond the IFN-gamma horizon: Biomarkers for immunodiagnosis of infection with M. tuberculosis. Eur Respir J 43: 1472-1486.
15. Cohn DL, El-Sadr WM (2006) Treatment of latent tuberculosis infection. In M.C. Raviglione, editor. Reichman and Hershfield's Tuberculosis: A Comprehensive International Approach, 3rd ed. Informa Healthcare, New York. 265-305.
16. Elzi L, Schlegel M, Weber R, Hirschel B, Cavassini M, et al. (2007) Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission. Clin Infect Dis 44: 94-102.
17. HIV-Causal Collaboration (2012) Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries. Clin Infect Dis 54: 1364-1372.
18. Kollan C, Bartmeyer B, Bergmann F, Bogner J, Fritzsche C, et al. Antiretroviral treatment (ART) outcome in a large prospective German HIV cohort study - how much virus is still out there?, 5. Deutsch-Österreichischer AIDS-Kongress, Hannover, June 15-18, 2011; PW 49, Abstact volume 61-62.
19. Sester M, van Leth F, Bruchfeld J, Bumbacea D, Cirillo DM, et al. (2014) Risk Assessment of Tuberculosis in Immunocompromised Patients - A TBNET Study. Am J Respir Crit Care Med.
20. Abgrall S, Del Giudice P, Melica G, Costagliola D, Fhdh-Anrs CO (2010) HIV-associated tuberculosis and immigration in a high-income country: incidence trends and risk factors in recent years. AIDS 24: 763-771.
21. Karo B, Haas W, Kollan C, Gunsenheimer-Bartmeyer B, Hamouda O, et al. (2014) Tuberculosis among people living with HIV/AIDS in the German ClinSurv HIV Cohort: long-term incidence and risk factors. BMC Infect Dis 14: 148.
22. Ringshausen FC, Suhling H, Bange FC, Welte T, Gottlieb J (2013) Tuberculosis after lung transplantation, Germany, 1993-2012. Poster number 4689, European Respiratory Conference, Barcelona, 7-11 September 2013.
23. Lange C, Rieder HL (2011) Intention to test is intention to treat. Am J Respir Crit Care Med 183: 3-4.
24. Ringshausen FC, Nienhaus A, Torres Costa J, Knoop H, Schlosser S, et al. (2011) Within-subject variability of Mycobacterium tuberculosis-specific gamma interferon responses in German health care workers. Clin Vaccine Immunol 18: 1176-1182.
25. Dorman SE, Belknap R, Graviss EA, Reves R, Schluger N, et al. (2014) Interferon-gamma release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States. Am J Respir Crit Care Med 189: 77-87.
26. Slater ML, Welland G, Pai M, Parsonnet J, Banaei N (2013) Challenges with QuantiFERON-TB Gold assay for large-scale, routine screening of U.S. healthcare workers. Am J Respir Crit Care Med 188: 1005-1010.
27. Nienhaus A, Schablon A, Preisser AM, Ringshausen FC, Diel R (2014) Tuberculosis in healthcare workers - a narrative review from a German perspective. J Occup Med Toxicol 9: 9.
28. Ringshausen FC, Nienhaus A, Schablon A, Torres Costa J, Knoop H, et al. (2013) Frequent detection of latent tuberculosis infection among aged underground hard coal miners in the absence of recent tuberculosis exposure. PLoS One 8: e82005.
29. Marks SM, Taylor Z, Qualls NL, Shrestha-Kuwahara RJ, Wilce MA, et al. (2000) Outcomes of contact investigations of infectious tuberculosis patients. Am J Respir Crit Care Med 162: 2033-2038.
30. Ferebee SH (1970) Controlled chemoprophylaxis trials in tuberculosis. A general review. Bibl Tuberc 26: 28-106.
31. Haldar P, Thuraisingam H, Patel H, Pereira N, Free RC, et al. (2013) Single-step QuantiFERON screening of adult contacts: a prospective cohort study of tuberculosis risk. Thorax 68: 240-246.
32. Moran-Mendoza O, Marion SA, Elwood K, Patrick D, FitzGerald JM (2010) Risk factors for developing tuberculosis: a 12-year follow-up of contacts of tuberculosis cases. Int J Tuberc Lung Dis 14: 1112-1119.
33. Pai M, Denkinger CM, Kik SV, Rangaka MX, Zwerling A, et al. (2014) Gamma interferon release assays for detection of Mycobacterium tuberculosis infection. Clin Microbiol Rev 27: 3-20.
34. Mulder C, van Deutekom H, Huisman EM, Toumanian S, Koster BF, et al. (2012) Role of the QuantiFERON(R)-TB Gold In-Tube assay in screening new immigrants for tuberculosis infection. Eur Respir J 40: 1443-1449.
35. Pareek M, Abubakar I, White PJ, Garnett GP, Lalvani A (2011) Tuberculosis screening of migrants to low-burden nations: insights from evaluation of UK practice. Eur Respir J 37: 1175-1182.
36. Horsburgh CR Jr, Goldberg S, Bethel J, Chen S, Colson PW, et al. (2010) Latent TB infection treatment acceptance and completion in the United States and Canada. Chest 137: 401-409.
37. Landry J, Menzies D (2008) Preventive chemotherapy. Where has it got us? Where to go next? Int J Tuberc Lung Dis 12: 1352-1364.
38. Leung CC, Rieder HL, Lange C, Yew WW (2011) Treatment of latent infection with Mycobacterium tuberculosis: update 2010. Eur Respir J 37: 690-711.
39. Valin N, Antoun F, Chouaid C, Renard M, Dautzenberg B, et al. (2005) Outbreak of tuberculosis in a migrants' shelter, Paris, France, 2002. Int J Tuberc Lung Dis 9: 528-533.
40. Liu Y, Painter JA, Posey DL, Cain KP, Weinberg MS, et al. (2012) Estimating the impact of newly arrived foreign-born persons on tuberculosis in the United States. PLoS One 7: e32158.
41. Gomez-Reino JJ, Carmona L, Valverde VR, Mola EM, Montero MD, et al. (2003) Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis Rheum 48: 2122-2127.
42. Brassard P, Kezouh A, Suissa S (2006) Antirheumatic drugs and the risk of tuberculosis. Clin Infect Dis 43: 717-722.
43. Korner MM, Hirata N, Tenderich G, Minami K, Mannebach H, et al. (1997) Tuberculosis in heart transplant recipients. Chest 111: 365-369.
44. Torre-Cisneros J, Doblas A, Aguado JM, San Juan R, Blanes M, et al. (2009) Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort. Clin Infect Dis 48: 1657-1665.
45. Bruce RM, Wise L (1977) Tuberculosis after jejunoileal bypass for obesity. Ann Intern Med 87: 574-576.
46. Pickleman JR, Evans LS, Kane JM, Freeark RJ (1975) Tuberculosis after jejunoileal bypass for obesity. JAMA 234: 744.
47. World Health Organization. Global tuberculosis control : epidemiology, strategy, financing : WHO Report 2009, Geneva, Switzerland; 2009.
48. Van den Broek J, Borgdorff MW, Pakker NG, Chum HJ, Klokke AH, et al. (1993) HIV-1 infection as a risk factor for the development of tuberculosis: a case-control study in Tanzania. Int J Epidemiol 22: 1159-1165.
49. Calvert GM, Rice FL, Boiano JM, Sheehy JW, Sanderson WT (2003) Occupational silica exposure and risk of various diseases: an analysis using death certificates from 27 states of the United States. Occup Environ Med 60: 122-129.
50. Cowie RL (1994) The epidemiology of tuberculosis in gold miners with silicosis. Am J Respir Crit Care Med 150: 1460-1462.
51. McAdam JM, Bucher SJ, Brickner PW, Vincent RL, Lascher S (2009) Latent tuberculosis and active tuberculosis disease rates among the homeless, New York, New York, USA, 1992-2006. Emerg Infect Dis 15: 1109-1111.
52. Tan de Bibiana J, Rossi C, Rivest P, Zwerling A, Thibert L, et al. (2011) Tuberculosis and homelessness in Montreal: a retrospective cohort study. BMC Public Health 11: 833.
53. Chia S, Karim M, Elwood RK, FitzGerald JM (1998) Risk of tuberculosis in dialysis patients: a population-based study. Int J Tuberc Lung Dis 2: 989-991.
54. Lundin AP, Adler AJ, Berlyne GM, Friedman EA (1979) Tuberculosis in patients undergoing maintenance hemodialysis. Am J Med 67: 597-602.
55. Baussano I, Williams BG, Nunn P, Beggiato M, Fedeli U, et al. (2010) Tuberculosis incidence in prisons: a systematic review. PLoS Med 7: e1000381.
56. Castaneda-Hernandez DM, Martinez-Ramirez JE, Bolivar-Mejia A, Rodriguez-Morales AJ (2013) Differences in TB incidence between prison and general populations, Pereira, Colombia, 2010-2011. Tuberculosis (Edinb) 93: 275-276.
57. Friedman LN, Williams MT, Singh TP, Frieden TR (1996) Tuberculosis, AIDS, and death among substance abusers on welfare in New York City. N Engl J Med 334: 828-833.
58. Girardi E, Sabin CA, d'Arminio Monforte A, Hogg B, Phillips AN, et al. (2005) Incidence of Tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America. Clin Infect Dis 41: 1772-1782.
59. Ku SC, Tang JL, Hsueh PR, Luh KT, Yu CJ, et al. (2001) Pulmonary tuberculosis in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 27: 1293-1297.
60. de la Camara R, Martino R, Granados E, Rodriguez-Salvanes FJ, Rovira M, et al. (2000) Tuberculosis after hematopoietic stem cell transplantation: incidence, clinical characteristics and outcome. Spanish Group on Infectious Complications in Hematopoietic Transplantation. Bone Marrow Transplant 26: 291-298.
61. Veening GJ (1968) Long term isoniazid prophylaxis. Controlled trial on INH prophylaxis after recent tuberculin conversion in young adults. Bull Int Union Tuberc 41: 169-171.
62. Bush OB Jr, Sugimoto M, Fujii Y, Brown FA Jr (1965) Isoniazid prophylaxis in contacts of persons with known tuberculosis. Second report. Am Rev Respir Dis 92: 732-740.
63. Coker R, McKee M, Atun R, Dimitrova B, Dodonova E, et al. (2006) Risk factors for pulmonary tuberculosis in Russia: case-control study. BMJ 332: 85-87.
64. Pablos-Mendez A, Blustein J, Knirsch CA (1997) The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics. Am J Public Health 87: 574-579.
65. Kim CH, Im KH, Yoo SS, Lee SY, Cha SI, et al. (2014) Comparison of the incidence between tuberculosis and nontuberculous mycobacterial disease after gastrectomy. Infection.
66. Steiger Z, Nickel WO, Shannon GJ, Nedwicki EG, Higgins RF (1976) Pulmonary tuberculosis after gastric resection. Am J Surg 131: 668-671.
67. Kim HA, Yoo CD, Baek HJ, Lee EB, Ahn C, et al. (1998) Mycobacterium tuberculosis infection in a corticosteroid-treated rheumatic disease patient population. Clin Exp Rheumatol 16: 9-13.
68. Yamada T, Nakajima A, Inoue E, Tanaka E, Hara M, et al. (2006) Increased risk of tuberculosis in patients with rheumatoid arthritis in Japan. Ann Rheum Dis 65: 1661-1663.
69. Ferebee SH, Mount FW (1962) Tuberculosis morbidity in a controlled trial of the prophylactic use of isoniazid among household contacts. Am Rev Respir Dis 85: 490-510.
70. Katz J, Kunofsky S, Damijonaitis V, Lafleur A, Caron T (1965) Effect of Isoniazid Upon the Reactivation of Inactive Tuberculosis; Final Report. Am Rev Respir Dis 91: 345-350.